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Effects of Brazilian propolis on Leishmania amazonensis
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Leishmaniasis, an endemic parasitosis that leads to chronic cutaneous, mucocutaneous or visceral lesions,
is part of those diseases, which still requires improved control tools. Propolis has shown activities against
different bacteria, fungi, and parasites. In this study we investigated the effect of four ethanolic extracts of
typified propolis collected in different Brazilian states, on Leishmania amazonensis performing assays with
promastigote forms, extracellular amastigotes, and on infected peritoneal macrophages. Ethanolic extracts of
all propolis samples (BRG, BRPG, BRP-1, and BRV) were capable to reduce parasite load as monitored by the
percentage of infected macrophages and the number of intracellular parasites. BRV sample called red propolis,
collected in the state of Alagoas, and containing high concentration of prenylated and benzophenones com-
pounds, was the most active extract against L. amazonensis. The anti-Leishmania effect of BRV sample was
increased in a concentration and time dependent manner. BRV treatment proved to be non-toxic to macrophage
cultures. Since BRV extract at the concentration of 25 µg/ml reduced the parasite load of macrophages while
presented no direct toxic to promastigotes and extracellular amastigotes, it was suggested that constituents of
propolis intensify the mechanism of macrophage activation leading to killing of L. amazonensis. Our results
demonstrate, for the first time, that ethanolic extracts of Brazilian propolis reduce L. amazonensis infection in
macrophages, and encourage further studies of this natural compound in animal models of leishmaniasis.
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Leishmaniasis is a parasitosis caused by several spe-
cies of the protozoan Leishmania and it is currently en-
demic in 88 countries. Overall prevalence is 12 million
people and the population at risk is 350 million (Desjeux
2004, Murray et al. 2005). Injected into mammalian
hosts by phlebotomus sand flies as extracellular promas-
tigotes, Leishmania bind to macrophage and are quickly
phagocytosed. All Leishmania species are obligatorily
intracellular parasites, which live within secondary
phagolissosomes. In this way, the parasite is able to mul-
tiply, lyse host cell, and infect surrounding macrophages.
The severity of disease varies ranging from cutane-
ous or mucosal to visceral or diffuse cutaneous infec-
tion (Grimaldi & Tesh 1993, Murray et al. 2005). The
former is generally caused by L. amazonensis, a spe-
cies transmitted mainly in the Amazon region, which is
associated with localized cutaneous lesions (Grimaldi
& Tesh 1993). Chemotherapy remains the mainstay for
the control of leishmaniasis, as effective vaccines have
yet to be developed (Murray et al. 2005). The first line
of therapy for all forms of the disease requires poten-
tially toxic and painful multiple injections of pentava-
lent antimonials (Berman 2003). The problem is further
aggravated by the appearance of resistance to these drugs
in some endemic areas. Amphotericin B and pentami-
dine are second-line drugs and they present limited value
because of their toxicity and difficulty in administration
(Berman 2003). Many studies have been conducted to
find an effective therapy for leishmaniasis that avoids
exposure to potentially toxic drugs, including screening
of plant extracts and plant-derived compounds (Abreu et
al. 1999, Carvalho & Ferreira 2001, Rocha et al. 2005).
Propolis is a resinous substance that honey bees
collect from different plant exsudates (Marcucci
1995). Propolis is claimed to posses versatile valu-
able pharmacological activities and has, to date, been
taken in internal and external dosage forms for the
treatments of various diseases (Burdock 1998, Mar-
cucci & Bankova 1999). It is widely used in products
like “healthy foods” and “biocosmetics” (Marcucci &
Bankova 1999). Many authors have reported the in
vitro activities of propolis against different microor-
ganisms, among them some important human patho-
gens, such as Staphylococcus aureus, Salmonella
thyphimurium, Candida albicans, Trypanosoma
cruzi, and Giardia duodenalis (Higashi & de Castro
1994, Marcucci et al. 2001, Miorin et al. 2003, Uzel
et al. 2005, Dantas et al. 2006, Freitas et al. 2006,
Trusheva et al. 2006). Brazilian propolis is the sub-
ject of an intensive study of chemists, biologists, and
physicians all over the world due to specific tropical
flora and their different chemical components
(Marcucci & Bankova 1999, Marcucci et al. 2001,
Trusheva et al. 2006).
This report describes in vitro analyses of the ef-
fects of ethanolic extracts of typified Brazilian pro-
polis samples on both promastigote and amastigote
forms of L. amazonensis and on macrophages infected
with the parasite.
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MATERIALS AND METHODS
Parasite - L. amazonensis (MHOM/BR/73/M2269)
promastigotes were cultured at 28oC in RPMI 1640
medium (Sigma, St. Louis, MO) supplemented with 25
µg/ml gentamicin, 2 mM L-glutamine, 100 mM HEPES,
and 10% fetal calf serum (FCS) (Cultilab, Campinas, SP,
Brazil), pH 7.2. Amastigotes were isolated from active
skin lesions from BALB/c mice, and used immediately
after isolation (Barbieri et al. 1993).
Brazilian propolis samples - Two propolis samples
collected in the Brazilian state of Paraná were green pro-
polis, typified as BRG and BRPG. Propolis collected in
the state of Minas Gerais was typified as BRP-1 (green
propolis) (Miorin et al. 2003) and the sample collected
in the state of Alagoas as BRV (red propolis) (Trusheva
et al. 2006). The ethanolic extracts of propolis were pre-
pared by using a modified technique described by Miorin
et al. (2003). Propolis (30 g) was cut into small pieces
and extracted with 100 ml absolute ethanol at room tem-
perature for 24 h. The solution was filtered with Whatman
paper number 3, and placed in amber flasks. Each solu-
tion was dried and the residue weighted to prepare stock
solution in ethanol at concentration of 5%. The final
concentration of the solvent in the experiments did not
exceed 0.1% ethanol.
Macrophage infection with L. amazonensis - Pri-
mary mouse macrophages (5 × 105/ml) were obtained
from normal BALB/c mice by peritoneal washing, cul-
tured on 24-well plates containing 13 mm diameter glass
coverslips and infected with amastigotes (3:1 parasite/
host cell) for 1 h, as described previously (Colhone et
al. 2004). After the interaction period, the cultures were
washed to remove extracellular parasites and incubated
in the presence or absence of different concentrations
of propolis or diluent (0.1% ethanol), at 37oC in 5%
CO2 in air in a humidified incubator as established by
Ayres et al. (2006). After the indicated periods of treat-
ments, coverslips were fixed with methanol, stained with
Giemsa, and examined under light microscope. Six hun-
dred cells were counted per triplicate coverslip for the
evaluation of the percentage of infected macrophages
and the number of amastigotes per infected macrophage
(Colhone et al. 2004). The infection levels were quanti-
fied using a light microscopy at 1000 magnification.
Assessment of propolis effects on L. amazonensis
promastigotes, amastigotes, and macrophage cultures
- Promastigotes growing in 25 cm2 plastic flasks at 28oC
were treated with different concentrations of propolis
or diluent, and parasite number and morphology were
determined using a Neubauer haemocytometer (Arrais-
Silva et al. 2005). Amastigotes maintained under pro-
mastigote culture conditions, i.e. at 28oC in 25 cm2 plas-
tic flasks with RPMI 1640 medium supplemented with
gentamicin, L-glutamine, HEPES, and 10% FCS, were
treated with different concentrations of propolis or
diluent, and left to transform into promastigote forms.
After the indicated periods of incubation at 28oC, pro-
mastigote and amastigote numbers were recorded by
microscopic observation (Lemesre et al 1997, Arrais-
Silva et al. 2005). Macrophages cultured on 24-well
plates were incubated for 72 h in the presence of differ-
ent propolis samples or diluent (0.1% ethanol). Cell vi-
ability was analyzed by a dye-reduction assay using MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) (Sigma) (Mosmann 1983).
Fig. 1: effect of ethanolic extracts of Brazilian propolis (25 µg/ml) on
Leishmania amazonensis- infected macrophages after 72 h of treatment:
control, 0.1% ethanol, BRG (      ) or BRPG (     ). The percentage of infected
macrophages (A) and the number of parasites per infected cell (B) were
determined as described in Materials and Methods. The results repre-
sent the mean ± SD of three independent experiments. Asterisks repre-
sent statistically differences (p < 0.01) between control and propolis-
treated cultures.
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Statistical analyses - All experiments were repeated
at least three times in triplicate wells. The results were
expressed as mean ± SD. Data obtained with different
propolis extracts were analyzed by 1-way ANOVA and
Student’s t-test (P < 0.01).
RESULTS
Experiments were undertaken to study a possible ef-
fect of four typified Brazilian propolis samples on L.
amazonensis-infected macrophage cultures. As shown
in Fig. 1 murine macrophages were efficiently infected
with L. amazonensis amastigotes (around 90% of in-
fected cells and 6 intracellular parasites per infected
cell). Macrophages infected with the parasite and treated
with 25 µg/ml of BRG and BRPG extracts for 72 h have
showed significant reduction of both the percentage of
infection (Fig. 1A) and of the number of intracellular
parasites (Fig. 1B). At concentrations higher than 25 µg/
ml both extracts were toxic to the cells, because light
microscopy showed cellular debris and few intact mac-
rophages present on the surface of glass cover slips and
in the culture supernatants. It must notice that at the per-
centage of 0.1% ethanol, amount present in experiments
performed, this solvent had no effect on the cultures.
The same protocol was employed to test BRP-1 and BRV
samples (Fig. 2). The extract from BRP-1 sample was
Fig. 2: effect of ethanolic extracts of Brazilian propolis (3-100 µg/ml) on
Leishmania amazonensis-infected macrophages after 72 h of treatment:
control, 0.1% ethanol, BRV ( ) or BRP-1 (     ). The percentage of infected
macrophages (A) and the number of parasites per infected cell (B) were
determined as described in Materials and Methods. The results repre-
sent the mean ± SD of three independent experiments; n.d.: not deter-
mined. Asterisks represent statistically differences (p < 0.01) between
control and propolis-treated cultures.
capable to reduce significantly the macrophage infec-
tion at concentrations ranging from 6 to 100 µg/ml. The
treatment with 6 µg/ml of BRV for 72 h led to a reduc-
tion of 84.5% of the infection level and at higher con-
centrations of the extract no infected macrophage was
observed. Since BRV was the most active, further ex-
periments were performed, treating the infected cultures
for 1, 2, and 3 days with 25 µg/ml of this extract, and
being observed a time-dependent decrease of both the
percent of infection and of the intracellular prolifera-
tion of the parasites (Fig. 3). The viability of macroph-
ages treated for 72 h with 0.1% ethanol, 25, 50 or 100
µg/ml BRV was further analyzed by MTT assay. Formazan
production was similar between control, macrophages
treated with 0.1% ethanol or with 100 µg/ml BRV (Fig.
4). Interestingly, treatment with 25 or 50 µg/ml of the
extract induced an increase in the MTT-reducing activity
(Fig. 4). Since peritoneal macrophages are non-dividing
differentiated cells (Handel-Fernandez & Lopez 2000),
we can exclude the possibility that BRV stimulates the
proliferation of macrophages.
We also addressed the question concerning whether
BRV extracts presented a direct effect on promastigotes
and extracellular amastigotes of L. amazonensis. Up to 96
h, at 25 µg/ml, the extract did not affect promastigotes pro-
liferation (Fig. 5A). In experiments with lesion-derived
Fig. 3: effect of BRV propolis extract (25 µg/ml) on Leishmania
amazonensis-infected macrophages after 24, 48, and 72 h of treatment:
control (      ), 0.1% ethanol (     ), and BRV (  ). The percentage of infected
macrophages (A) and the number of parasites per infected cell (B) were
determined as described in Materials and Methods. The results repre-
sent the mean ± SD of three independent experiments. Asterisks repre-
sent statistically differences (p < 0.01) between control and propolis-
treated cultures.
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amastigotes, 25 µg/ml BRV did not interfere with their vi-
ability (around 98% of control viability after 24 h of treat-
ment) or with their morphology (data not shown). Previous
studies indicated that even if amastigotes remain viable,
only molecularly undamaged amastigotes are expected to
be able to transform into promastigotes (Lemesre et al.
1997, Arrais-Silva et al. 2005). Addition of 25 µg/ml BRV
in medium did not affect amastigotes differentiation to
promastigotes (48 h) (Fig. 5B).
DISCUSSION
This report provided evidences that ethanolic extracts
of Brazilian propolis reduced L. amazonensis infection
in macrophage cultures. Based on high performance liq-
uid chromatography and nuclear magnetic resonance
analysis ethanolic extract of Brazilian propolis samples
have been typified in four groups (Marcucci 2000). BRG
contains high concentration of coniferaldehyde com-
pounds, BRPG contains high concentration of prenylated
and coniferaldehyde compounds, BRP-1 contains high
concentration of prenylated compounds and BRV con-
tains high concentration of prenylated and benzophe-
nones compounds (Marcucci & Bankova 1999, Marcucci
et al. 2001, Miorin et al. 2003, Sawaya et al. 2004,
Trusheva et al. 2006). The four propolis samples (BRG,
BRPG, BRP-1, and BRV) evaluated in this study were
able to reduce parasite load, as monitored by the per-
centage of infected cells and the number of intracellular
parasites. Additional experiments with BRG and BRPG
samples were abandoned because at concentrations
higher than 25 µg/ml both extracts were toxic to mac-
rophages.  In fact some studies have demonstrated pro-
polis toxicity for different cell types (Higashi & de Castro
1994, Chen et al. 2001, Ferguson 2001, Dantas et al.
2006, Tavares et al. 2006). For example, damage to mu-
rine macrophages was observed after treatment with
ethanolic extract of propolis at concentrations above 30
µg/ml (Higashi & de Castro 1994), and genotoxic effect
of ethanolic extract of Brazilian propolis (100 µg/ml)
was detected in Chinese hamster ovary cells (Tavares et
al. 2006). The mechanism of propolis cytotoxicity is still
unknown (Tavares et al. 2006). On the other hand, BRP-
1 and BRV extracts were not toxic to macrophages and
inhibited the intracellular proliferation of L. ama-
zonensis. The BRV extract was the most active and treat-
ment of macrophages led to no morphological alterations
as judged by light microscopy. Interestingly, 25 or 50
µg/ml BRV extract induced in macrophages an increase
of the MTT-reducing activity. These results are appar-
ently paradoxical, since macrophages are non-dividing
cells (Handel-Fernandez & Lopes 2000), but the present
results match those obtained with interferons and plant-
derived polyphenols, which induce cell cycle arrest in
cancer lineages but increase MTT-reducing activity (Jab-
ber et al. 1989, Pagliacci et al. 1993, Bernhard et al.
2003). Such increase may be attributed to an increase in
cell volume and mithocondrial number and/or activity
of cells treated with the BRV extract (Bernhard et al.
2003). Although BRV is active against intracellular para-
sites it presented no direct effect on promastigotes or
extracellular amastigotes. Our data corroborate results
Fig. 5: effect of BRV propolis extract on Leishmania amazonensis pro-
mastigotes and extracellular amastigotes. A: promastigotes were left untre-
ated (), treated at 28oC with 0.1% ethanol (     ), 25 µg/ml BRV extract (    )
up to 96 h. Parasite viability was assessed by microscopic examination;
B: extracellular amastigotes were left untreated (    ), treated at 28oC with
0.1% ethanol (   ) or 25 µg/ml BRV extract (   ). The transformation of
amastigotes into promastigotes was monitored after 24 h and 48 h. These
are the results of a typical experiment, representative of a total of 3.
Fig. 4: MTT production by non-infected macrophages: control, 0.1%
ethanol, 88 mM H2O2, or BRV extract at 25, 50, 100 µg/ml. The results
represent the mean ± SD of three independent experiments. Asterisks
represent statistically differences (p < 0.01) between control, H2O2 and
BRV-treated cultures.
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obtained by Higashi and de Castro (1994). The authors
observed that concentrations of ethanolic extract of pro-
polis that inhibited the levels of T. cruzi infection in
macrophages did not affect proliferation of axenic
amastigotes. These results and our findings suggest that
factors associated with host cell metabolism may con-
tribute to intensify the effects of propolis (Higashi &
de Castro 1994). Another possibility is that constitu-
ents of propolis intensify the mechanism of macroph-
age activation, leading to production of cytokines and
reactive nitrogen intermediates engaged in the killing of
intracellular parasites (Solbach & Laskay 2000). It was
demonstrated that Korean propolis induces macrophages
by producing interleukin-1, tumor necrosis factor-α, and
nitric oxide (Han et al. 2002); these results suggest that
propolis may function through macrophage activation.
The precise mechanism by which BRV propolis treated
macrophages are able to control L. amazonensis infec-
tion needs further investigations. This sample was col-
lected in Alagoas, Brazil and it is a new propolis type
called red Brazilian propolis containing high concentra-
tion of prenylated and benzophenones compounds
(Marcucci 2000, Trusheva et al. 2006). The recent study
of Trusheva et al. (2006) identified 14 chemical constitu-
ents of red Brazilian propolis, three of them with antibac-
terial and antimycotic activities, and encourages further in-
vestigations of the chemical constituents which are respon-
sible for the leishmanicidal activities of red Brazilian pro-
polis showed in this report. The investigation in animal mod-
els of Leishmania infection is currently under investiga-
tion in our laboratory.
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